Hair Repigmentation with Anti-PD-1 and Anti-PD-L1 Immunotherapy: a Novel Hypothesis
Manson, G.; Marabelle, A.él.; Houot, R.
JAMA Dermatology 154(1): 113
2018
ISSN/ISBN: 2168-6084 PMID: 29167871 DOI: 10.1001/jamadermatol.2017.4421
Accession: 059784558
Full Text Article emailed within 0-6 h: $19.90
Related References
Sebaratnam, D.Frank.; Rodríguez Bandera, A.Isabel.; Lowe, P.Margaret. 2018: Hair Repigmentation With Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis JAMA Dermatology 154(1): 112-113Rivera, N.; Boada, A.; Bielsa, M.Isabel.; Fernández-Figueras, M.Teresa.; Carcereny, E.; Moran, M.Teresa.; Ferrándiz, C. 2017: Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer JAMA Dermatology 153(11): 1162-1165
Holmes, Z.; Courtney, A.; Hiong, A. 2022: Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy BMJ Case Reports 15(8)
Chan, C.; Magro, C.M.; Pham, A.Khoa.; LeBlanc, R.E.; Yan, S.; Barton, D.T.; Pace, N.C.; Chapman, M.Shane.; Momtahen, S. 2019: Spontaneous Hair Repigmentation in an 80-Year-Old Man: A Case of Melanoma-Associated Hair Repigmentation and Review of the Literature American Journal of Dermatopathology 41(9): 671-674
Abelson, N.M.; Rawson, A.J. 1961: Studies of blood group antibodies. V. Fractionation of examples of anti-A,B, anti-M, anti-P, anti-Jka, anti-Lea, anti-D, anti-CD, anti-K, anti-Fya, anti-s and anti-Good Transfusion 1(2): 116-123
Abelson, N.M.; Rawson, A.J. 1961: Studies of blood group antibodies, V. Fractionation of examples of anti-B, anti-A,B, anti-P, anti-Jka, anti-Lea, anti-D, anti-CD, anti-K, anti-Fya, anti-s and anti-Good Transfusion 1: 116-123
Higginbotham, S.; Wong, W.R.; Linington, R.G.; Spadafora, C.; Iturrado, L.; Arnold, A.E. 2014: Sloth hair as a novel source of fungi with potent anti-parasitic, anti-cancer and anti-bacterial bioactivity Plos one 9(1): E84549
Xiang, Z.; Li, J.; Zhang, Z.; Cen, C.; Chen, W.; Jiang, B.; Meng, Y.; Wang, Y.; Berglund, B.ör.; Zhai, G.; Wu, J. 2022: Comprehensive Evaluation of Anti-PD-1, Anti-PD-L1, Anti-CTLA-4 and their Combined Immunotherapy in Clinical Trials: a Systematic Review and Meta-analysis Frontiers in Pharmacology 13: 883655
Hao, C.; Tian, J.; Liu, H.; Li, F.; Niu, H.; Zhu, B. 2017: Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials Medicine 96(26): E7325
Colin, M.; Dujardin, S.; Schraen-Maschke, S.; Meno-Tetang, G.; Duyckaerts, C.; Courade, J-Philippe.; Buée, L. 2020: From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy Acta Neuropathologica 139(1): 3-25
Wirquin, V. 1997: Informations réactifs : exploration thyroïdienne - III : thyroglobuline (TG) - Ac antithyroglobuline (anti-TG, TG AB) - Ac antirécepteurs de tsh (anti-R-TSH, RB AB) - Ac antithyroperoxydase (anti-TPO, AB TPO) - Ac antimicrosomes (TM AB) - Information on reagents : thyroid function tests - III: thyroglobulin (TG) anti-TG Ab, anti-microsome AB, anti-TPO AB, anti-TSH-receptor AB Immuno Analyse and Biologie Specialisee 12(5): 286-289
Kochetkova, V.A. 1967: Effect of poly vinyl pyrrolidone pharm adjunct on the anti tumor and toxic properties in some anti blastomatous preparations rat thiotepai anti neoplastic benzo tepa anti neoplastic phosphazine anti neoplastic 5 fluoro uracil anti neoplastic auranthin anti neoplastic cyclo phosphane anti neoplastic spiridazine anti neoplastic olivomycin anti neoplastic Farmakologiya i Toksikologiya (Moscow) 30(6): 740-745
Saung, M.T.; Zheng, L. 2019: Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma Annals of Pancreatic Cancer 2
Mathe, G.; Schwarzenberg, L.; Amiel J L.; Schneider, M.; Cattan, A.; Schlumberger J R. 1968: Treatment of acute neopl lympho blastic leukemia in remission with radiation of the cns and 8 drugs in succession abstract from sem hop paris 42 49 2960 2965 nov 1966 prednisone anti neoplastic vinleurosine anti neoplastic vinca rosea d leurosine anti neoplastic leurocristine anti neoplastic methotrexate anti neoplastic amethopterin anti neoplastic azathio purine anti neoplastic cyclophosphamide anti neoplastic cytoxan anti neoplastic endoxan anti neoplastic methyl bis glyoxal anti neoplas Drug Digests 3(1): 25, 1967
Hirose, Y.; Simon, J.A.; Ou, H.C. 2011: Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral line Journal of the Association for Research in Otolaryngology: Jaro 12(6): 719-728
Bertelli, A. 1968: Enz proteases and anti proteasic substances in the inflammatory response enz trypsin anti inflam enz alpha chymotrypsin anti inflam enz acid phosphatase anti inflam enz pronase anti inflam enz kallikrein anti inflam enz collagenase anti inflam enz elastase anti inflam enz plasmin anti inflam epsilon amino caproic acid anti inflam epsilon acetamido caproic acid anti inflam aminomethyl cyclo hexanrecarboxylic acid anti inflam iniprol anti inflam trasylol anti inflam rat guinea pig rabbit Biochemical Pharmacology : 229-240
Tobin, E.; Denardo, G.; Zhang, N.; Epstein, A.L.; Liu, C.; Denardo, S. 2007: Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines Leukemia and Lymphoma 48(5): 944-956
Antar, S.A.; Saleh, M.A.; Al-Karmalawy, A.A. 2022: Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2 Life Sciences 309: 121048
Seppelt, W.; Rucker, C.; Kaiser, C.; Prinzbach, H. 1984: Funktionalisierte Dioxide (syn-1,4) und Trioxide (anti,anti) des Tropilidens - Dioxydes (syn-1,4) et trioxydes (anti, anti) fonctionnalisés du tropylidène - Functionalised dioxides (syn-1,4) and trioxides (anti, anti) of tropilidene Chemische Berichte 117(5): 1834-1855
Youinou, P.; Saraux, A.; Jamin, C.; Baron, D.; Le Goff, P. 2000: Anticorps anti-périnucléaires, anti-kératine et anti-filaggrine en rhumatologie - Anti-perinuclear, anti-keratin and anti-filaggrin antibodies in rheumatology L' Eurobiologiste (Paris) 34(247): 59-62